Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Risk Factors for Hearing Loss in Patients with Cystic Fibrosis.

Tarshish Y, Huang L, Jackson FI, Edwards J, Fligor B, Wilkins A, Uluer A, Sawicki G, Kenna M.

J Am Acad Audiol. 2016 Jan;27(1):6-12. doi: 10.3766/jaaa.14104.

PMID:
26809322
2.

Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome.

Gordon LB, Kleinman ME, Miller DT, Neuberg DS, Giobbie-Hurder A, Gerhard-Herman M, Smoot LB, Gordon CM, Cleveland R, Snyder BD, Fligor B, Bishop WR, Statkevich P, Regen A, Sonis A, Riley S, Ploski C, Correia A, Quinn N, Ullrich NJ, Nazarian A, Liang MG, Huh SY, Schwartzman A, Kieran MW.

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16666-71. doi: 10.1073/pnas.1202529109. Epub 2012 Sep 24.

3.

Pediatric hearing assessment by auditory brainstem response in the operating room.

Dornan B, Fligor B, Whittemore K, Zhou G.

Int J Pediatr Otorhinolaryngol. 2011 Jul;75(7):935-8. doi: 10.1016/j.ijporl.2011.04.010. Epub 2011 May 14.

PMID:
21571378
4.

Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss.

Kenna MA, Feldman HA, Neault MW, Frangulov A, Wu BL, Fligor B, Rehm HL.

Arch Otolaryngol Head Neck Surg. 2010 Jan;136(1):81-7. doi: 10.1001/archoto.2009.202.

5.

Sensorineural hearing loss in patients with cystic fibrosis.

Cheng AG, Johnston PR, Luz J, Uluer A, Fligor B, Licameli GR, Kenna MA, Jones DT.

Otolaryngol Head Neck Surg. 2009 Jul;141(1):86-90. doi: 10.1016/j.otohns.2009.03.020.

PMID:
19559964
6.

Ototoxicity in children treated for osteosarcoma.

Lewis MJ, DuBois SG, Fligor B, Li X, Goorin A, Grier HE.

Pediatr Blood Cancer. 2009 Mar;52(3):387-91. doi: 10.1002/pbc.21875.

PMID:
19061216

Supplemental Content

Loading ...
Support Center